Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

AbbVie and NeuroDerm race to US launch of levodopa infusions intensifies with additional benefits highlighted at AAN 2024, says GlobalData

Innovation in drug formulations and delivery systems is one of the most rapidly changing areas in Parkinson’s disease (PD) treatment and is primarily driven by the levodopa market. At the American Academy of Neurology (AAN) 2024 Annual Meeting, data on NeuroDerm’s ND0612 (levodopa/carbidopa, LD/CD) and AbbVie’s Produodopa/Vyalev (foslevodopa/foscarbidopa) were showcased for the treatment of PD […]
Read more

Eli Lilly’s double impact: Mounjaro and Donanemab set to outshine market rivals, says GlobalData

Eli Lilly and Co is on the brink of reshaping the pharmaceutical landscape with its groundbreaking treatments, Mounjaro (tirzepatide) for obesity and the highly anticipated donanemab for early symptomatic Alzheimer’s disease. Both drugs are poised to exceed market expectations and challenge existing industry leaders, marking significant milestones in Eli Lilly’s journey toward market dominance, according […]
Read more

Global telcos lead the way in digital inclusion, finds GlobalData

Initiatives sponsored by global telcos set the standard for digital inclusion by promoting digital skills development, accessibility, and affordability for the disadvantaged in both underdeveloped and developed nations, says GlobalData, a leading data and analysis company. Digital inclusion involves facilitating access to information and resources via devices and connectivity suitable for the 21st Century. It […]
Read more
,

Top 50 APAC firms amass over $650 billion in MCap in Q1 2024, reveals GlobalData

The Asia-Pacific (APAC) region, which includes several of the world’s fastest-growing economies, performed strongly in the first quarter of 2024. This led to an increase in the market capitalization (MCap) of companies within the region. China moving away from lockdowns, strong domestic demand in India and Indonesia, and better-than-expected corporate earnings across the region led […]
Read more

US to see surge in new obesity drug launches in next five years, says GlobalData

Over the past two decades, there has been a marked increase in obesity rates among US adults, with projections indicating a continuing upward trend. Two blockbuster drug launches within the last few years—Novo Nordisk’s Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide)—have highlighted the lucrative potential offered by this market. Encouraged by the performance of these […]
Read more

Future looks bright for allergy testing market with vast pipeline of IVD devices, says GlobalData

As spring hits many countries this month, it ushers in warmer weather and seasonal allergies for millions around the world. Pollen levels have been shown to have increased across regions due to climate, vegetation, and urbanization. As precision medicine and personalized medical approaches progress, so does understanding what exactly is causing an allergic reaction and […]
Read more

Basilea’s Zevtera will play unique yet critical role in MRSAB as first new therapy to gain FDA approval in over 15 years, says GlobalData

The FDA has approved Basilea Pharmaceutica’s advanced generation cephalosporin antibiotic, Zevtera (ceftobiprole medocaril), for the treatment of three major indications: Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP). As the first drug to reach the US market for the treatment of SAB in […]
Read more
, ,

Augmented reality will help sports companies engage with fans and intensify media competition, says GlobalData

The global sports industry faces various challenges, including maintaining fan engagement and intensifying media competition for sports broadcasting rights. Augmented reality (AR) can help sports companies tackle these challenges by creating more engaging and insightful viewing experiences, and the overall AR market is forecast to grow at a compound annual growth rate (CAGR) of 21% […]
Read more

Adaptogens on cusp of becoming mainstream ingredients, says GlobalData

Since the onset of the COVID-19 pandemic, functional drinks have been gaining momentum, with nootropics, immunomodulators, and botanics becoming household terms. Adaptogens, which claim to address rising concerns of stress, anxiety, and balance restoration, have been gaining ground rapidly. In addition, these ingredients help address the challenge of providing consumers with value for money by […]
Read more

Property insurers in Taiwan expected to remain profitable despite recent earthquake, says GlobalData

The 7.2 magnitude earthquake that struck Taiwan’s east coast recently has brought significant challenges to the insurance industry. Despite causing substantial damage, particularly in Hualien with collapsed buildings and infrastructure disruptions, insurers are expected to weather the financial impact well. Government-backed schemes are anticipated to mitigate losses, although insurers may re-evaluate risk exposure and adjust […]
Read more
1 … 80 81 82 83 84 … 136